baber/WOPTO huggingface dataset:
Patent DK-2175399-T3 (DK)
Inventor: OFFERMANN WOLFGANG
IPC: G06K19/077
Filed: 2009-10-13
Granted: 2011-10-24
Abstract: The transponder (2) has a control element connected with a reception element, a transmission element and a visual display unit (6). A transponder identification information unit and a state/operational information unit are read from a memory element via the transmission element. The state/operational information unit is supplied to the memory element via the reception element. The transponder is designed such that a portion of the information contained in the state/operational information unit is displayed on the display unit. Independent claims are also included for the following: (1) an information system comprising a communication system and a transponder (2) a method for operating an information system.
Patent DK-2308491-T3 (DK)
Inventor: BRADFORD WILLIAMSON ZIEGLER
IPC: A61K31/4412
Filed: 2010-03-03
Granted: 2012-01-09
Abstract: The present invention relates to methods involving avoiding adverse drug interactions with pirfenidone and CYP inducers, such as smoking.
Patent DK-3013805-T3 (DK)
Inventor: BLUM ANDREAS
IPC: C07D495/10
Filed: 2014-06-23
Granted: 2018-04-23
Abstract: This invention relates to novel sulfoximine substituted quinazoline derivatives of formula I wherein Ar, R1 and R2 are as defined in the description and claims, and their use as MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) kinase inhibitors, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of MNK1 (MNK1a or MNK1b) and/or MNK2 (MNK2a or MNK2b) mediated disorders.
Patent DK-3180954-T3 (DK)
Inventor: AXMON JOAKIM
IPC: H04W88/08
Filed: 2015-08-04
Granted: 2018-01-02
Abstract: A wireless device (120) and method for performing cell configuration. The wireless device and a first network node (111) serving the wireless device are operating in a wireless communications network (100), wherein the first network node manages a first serving cell (111a). When the wireless device is to send a second Random Access (RA) transmission in the first serving cell to the first network node while preparing to perform or performing configuration of a second serving cell managed by a second network node, the wireless device configures the second serving cell using a configuration time delay T act_PSCell  comprising at least a time delay T RA_PCell  due to the second RA transmission, otherwise the wireless device configures the second serving cell using the configuration time delay T act_PSCell  excluding the time delay T RA_PCell  due to the second RA transmission.
Patent DK-0406790-T3 (DK)
Inventor: ZARINI FRANCO
IPC: A61P31/04
Filed: 1990-07-03
Granted: 1996-01-29
Abstract: There is provided a process for the preparation of compounds of formula (I) useful as antibacterials: <CHEM> wherein R represents hydrogen atom or a hydroxy protecting group, which process comprises reacting a compound of formula (II) <CHEM> wherein R is as defined above, with an oxalyl halide in an inert solvent; optionally converting the resultant compound of the formula III <CHEM> wherein R is as defined above and X is a halogen atom into a compound of the formula III in which X represents a hydroxy group by hydrolysis; either (i) treating the compound of formula III in which X is a halogen atom with a compound of the formula IV <CHEM> wherein Y is a hydroxy group in the presence of an acid scavenger or an organic or inorganic base or (ii) treating the compound of the formula III in which X is a hydroxy group, with a compound of the formula IV in which Y is a leaving group in the presence of a base; cyclizing the resultant compound of the formula V <CHEM> wherein R is as defined above and optionally deprotecting the resultant compound of the formula I wherein R is a hydroxy protecting group to obtain a compound of the formula I wherein R is a hydrogen atom.
Patent DK-0458895-T3 (DK)
Inventor: MILLER STEPHEN J
IPC: C10G25/03
Filed: 1990-02-20
Granted: 1995-11-06
Abstract: The present invention relates to a process for producing a lube oil having a low pour point and excellent viscosity and viscosity index comprising isomerizing a waxy feed over a catalyst comprising a molecular sieve having generally oval 1-D pores having a minor axis between about 4.2  ANGSTROM  and about 4.8  ANGSTROM  and a major axis between about 5.4  ANGSTROM  and about 7.0  ANGSTROM  and at least one group VIII metal. SAPO-11, SAPO-31, SAPO-41, ZSM-22, ZSM-23 and ZSM-35 are examples of useful catalysts.
Patent DK-0470105-T3 (DK)
Inventor: SCHEER HANS
IPC: C09J113/02
Filed: 1990-04-17
Granted: 1994-11-21
Abstract: The invention concerns an aqueous binder dispersion for vulcanizing rubber on to substrates which are stable under the conditions of vulcanization, consisting of: a halogenated copolymer which, in addition to other components, contains an alkylation-active monoalkenylaromatic alkyl halide; polyfunctional aromatic nitroso compounds; pigments, carbon black, anti-foaming agents, emulsifiers and other additives. The aim of the invention is to improve the adhesive strength, at the same time avoiding the use of capped isocyanates. This is done by adding, to increase the adhesive strength, homopolymers or copolymers of vinyl acetate, which are also saponified to a certain extent, as well as, optionally, other customary additives.
Patent DK-0497978-T3 (DK)
Inventor: KAKEYA NOBUHARU
IPC: C07D501/22
Filed: 1990-10-24
Granted: 1997-10-20
Abstract: Cephalosporin compounds represented by general formula (I), pharmacologically acceptable addition salts thereof, method for the production thereof, and medicinal uses thereof, wherein R<1> represents hydrogen or lower alkyl, and R<2> represents 1-alkanoyloxyalkyl or 1-alkoxycarbonyloxy-alkyl. These compounds and salts not only can be readily absorbed through the digestive tract to exhibit wide antibacterial activities in vivo in the form of the hydrolyzates thereof, but also have remarkable sweetness 10 to 400 times as high as that of sucrose. Therefore they are useful in preventing and treating infectious diseases by oral administration. <CHEM>
Patent DK-0439079-T3 (DK)
Inventor: DENICOLA ANTHONY J JR
IPC: C08F255/00
Filed: 1991-01-19
Granted: 1996-05-06
Abstract: Disclosed is a method of making graft copolymers of olefin polymers by contacting a particulate olefin polymer with a free radical polymerization initiator, e.g., a peroxide, and a vinyl monomer at about from 60 DEG  to 125 DEG  C, while controlling the monomer addition rate so that it does not exceed about 4.5 pph/min, and most preferably does not exceed about 3.0 pph/min, at any monomer feed level. To prevent polymer degradation, a non-oxidizing environment is maintained throughout the process, and residual free radicals are deactivated, and unreacted initiator is decomposed, before the graft copolymer is exposed to air.
Patent DK-0461450-T3 (DK)
Inventor: EBERLEIN HELMUT DR
IPC: E04B1/19
Filed: 1991-05-24
Granted: 1993-02-15
Abstract: It is known to connect tubular members (10) for space frames to node pieces (11) by mean of cap screws (12) at their ends and to mount these cap screws (12) rotatably and axially displaceably in the end regions of the members (10). Their axial movement outwards is limited in each case by a stop which has hitherto been formed by bending end portions (21) of the members (10) into the interior of the tubular members. In this case, however, there is the risk that the end portions (21) become excessively deformed or compressed when joining the members. To avoid this, according to the invention the end portions (21) are each engaged, in fitting fashion, into a coaxial annular groove (26) on the inner annular end face of the screw cap (25), the end portion (21) positively embracing the annular, coaxial projection (27) radially outwardly adjoining the groove (26), on the screw cap (25). <IMAGE>
Patent DK-0450909-T3 (DK)
Inventor: LEBARON JAMES BROWNLOW
IPC: H01R24/84
Filed: 1991-04-02
Granted: 1996-02-26
Abstract: A hermaphroditic coupling mechanism includes two identical coupling members (4, 5), each including two latch arms (6, 7) and two detented locking ramp surfaces (15, 21). The latch arms include surfaces (10, 11) which face a coupler interface (19, 20), while the locking ramp surfaces face away from the interface. The latch arms are inserted through grooves (24) in a collar (17, 18) on which the locking ramp surfaces are provided, and the members are then rotated relative to each other causing the surfaces on the latch arms to pass over detents (22) on the locking surfaces, thereby locking the coupling members together against relative axial movement. The coupling members may be secured to respective contacts by a snap-fit arrangement (26, 28-33, and 46). <IMAGE>
Patent DK-0516642-T3 (DK)
Inventor: MAYER ADOLF
IPC: B26D7/26
Filed: 1991-02-08
Granted: 1994-05-30
Abstract: PCT No. PCT/EP91/00237 Sec. 371 Date Jul. 17, 1992 Sec. 102(e) Date Jul. 17, 1992 PCT Filed Feb. 8, 1991 PCT Pub. No. WO91/12938 PCT Pub. Date Sep. 5, 1991.Rotary shears for dividing sheet steel strips for sheet steel panels into several bands including a machine frame, two blade shafts rotatably mounted in a machine frame at an adjustable distance apart and at least one of which is driven, roller blades which can be positioned axially on the blade shafts, a manipulator which can slide on the machine frame parallel to the blade shafts and which positions the roller blades axially on the blade shafts and releasable clamps for clamping the roller blades on the blade shafts in predetermined positions. All roller blades can be positioned on the blade shafts individually and independently of each other by the manipulator and can be clamped on the blade shafts individually and independently of each other by the clamps.
Patent DK-0555229-T3 (DK)
Inventor: CHAKRABARTI AJOY
IPC: A61K38/00
Filed: 1991-07-25
Granted: 1996-08-19
Abstract: The present invention relates to liposomal compositions having a concentration gradient which load amino acids and peptides exhibiting weak acid or base characteristics into liposomes. Specifically loaded into liposomes by the methods of the present invention are C-terminal substituted amino acids or peptides. The liposomes are preferably large unilamellar vesicles. The concentration gradient is formed by encapsulating a first medium in the liposomes, said medium having a first concentration of the one or more charged species, and suspending the liposomes in a second medium having a second concentration of the one or more charged species, such as for example a pH gradient. Also disclosed are pharmaceutical preparations comprising such C-terminal substituted amino acids or peptides which have been loaded into the liposomes by the method of the invention.
Patent DK-0519263-T3 (DK)
Inventor: BAUER PETER
IPC: F16L7/00
Filed: 1992-06-02
Granted: 1995-05-29
Abstract: The invention proposes a sealing element for pipes in which cables and pipes are laid in a symmetrical or asymmetrical arrangement, an upper pressure plate (1) and a lower pressure plate (2) having clamping elements and clamping toggles (4, 5) being provided, and there being bushings (D2, D3) of different diameter for the cables and pipes. <IMAGE>
Patent DK-0506369-T3 (DK)
Inventor: BOOHER RICHARD NOLAN
IPC: A61P9/12
Filed: 1992-03-25
Granted: 1999-04-26
Abstract: 6-Heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz-[cd]indoles are provided which are useful in modifying the function of serotonin in mammals.
Patent DK-0563153-T3 (DK)
Inventor: NEUSTADT BERNARD R
IPC: A61P25/04
Filed: 1991-12-19
Granted: 1995-05-29
Abstract: Novel N-(mercaptoalkyl)amides of the formula  <IMAGE>  wherein R1 is lower alkyl, cyclolower alkyl, aryl or heteroaryl; R2 is (COR3)-aryl, heteroaryl, substituted (COR3)-aryl or substituted heteroaryl, wherein the substituents are 1-3 substituents selected from the group consisting of carboxy, alkoxycarbonyl, lower alkyl, hydroxy, halo, lower alkoxy, cyclolower alkyl, cyano, trifluoromethyl, phenyl, phenoxy and phenylthio; R3 is -OR4 or -NR4R5; R4 and R5 are independently selected from the group consisting of hydrogen, lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl and aryl lower alkyl, or R4 and R5 together with the nitrogen to which they are attached form a 5-, 6- or 7-membered ring; Q is hydrogen or R6CO-; R6 is hydrogen, lower alkyl or aryl; and m is 1 or 2; and the pharmaceutically acceptable salts thereof useful in the treatment of cardiovascular disorders, nephrotoxicity and pain conditions and combinations of N-(mercaptoalkyl)amides and atrial natriuretic factors or angiotensin converting enzyme inhibitors useful for treating cardiovascular disorders are disclosed.
Patent DK-0542944-T3 (DK)
Inventor: MAKIVIC MIJODRAG
IPC: E05B47/00
Filed: 1992-04-23
Granted: 1996-06-03
Abstract: A lock with motor-driven rotating cylinder core(s) (12) is characterized in that the drive shaft (10) of the motor (8) is located inside a ring (13) connected to rotate with the cylinder housing (15), the drive shaft (10) and the ring (13) also being connected to rotate with each other.
Patent DK-0586535-T3 (DK)
Inventor: ROUFA DIKLA
IPC: A61P31/04
Filed: 1992-05-29
Granted: 2001-03-05
Abstract: The present invention relates to the discovery that biocompatible anionic polymers can effectively inhibit fibrosis, scar formation, and surgical adhesions. The invention is predicated on the discovery that anionic polymers effectively inhibit invasion of cells associated with detrimental healing process, and in particular, that the effectiveness of an anionic polymer at inhibiting cell invasion correlates with the anionic charge density of the polymer.The present invention therefore relates to the use of a composition comprising an amount of pentosan polysulfate effective to inhibit fibrosis, in the manufacture of a medicament for inhibiting fibrosis of a lesion in a mammal.The present invention also provides a method for preparing a surgical implant for inhibiting fibrosis at the site of administration of the implant.
Patent DK-0582182-T3 (DK)
Inventor: MARTIN LAWRENCE LEO
IPC: A61K31/40
Filed: 1993-07-27
Granted: 2000-04-25
Abstract: The present invention relates to compounds of the general formula   <CHEM>  wherein   R1 is   hydrogen or loweralkyl; R2 is   hydrogen, loweralkyl, hydroxyloweralkyl, acyloxyloweralkyl or loweralkoxyloweralkyl; R3 is   hydrogen or loweralkyl;  or R2 and R3   taken together form a cycloalkyl ring of 3 to 7 carbon atoms; R4 is   hydrogen, loweralkyl, aryl or arylloweralkyl; R5 is   hydrogen, loweralkyl, acyl, aryloxycarbonyl, loweralkoxycarbonyl, or arylloweralkoxycarbonyl; X is   hydrogen, halogen, cyano, loweralkyl, aryl, arylloweralkyl, hydroxyloweralkyl, arylhydroxyloweralkyl, aminoloweralkyl, loweralkylaminoloweralkyl, diloweralkylaminoloweralkyl, arylsulfonyl, loweralkylsulfonyl; m and n are   independently 0 to 5 with the proviso that the sum of m and n does not exceed 5; p is   0, 1 or 2; and wherein the dotted line between the pyrrole ring and the carbonyl group represents an optional bond; when said bond ist present, R6 is hydrogen, loweralkyl, hydroxy, loweralkoxy, amino, loweralkylamino, diloweralkylamino, or <CHEM> where Y is hydrogen, halogen, loweralkyl, loweralkoxy, hydroxy, trifluormethyl or nitro; or heteroaryl selected from <CHEM> where Z is hydrogen, halogen or loweralkyl, with the proviso that when m and n are each zero and when R2 and R3 are each hydrogen and R6 is phenyl or substituted phenyl and together with he carbonyl group is attached at the 2-position of the pyrrole ring, Y cannot be hydrogen, halogen, trifluoromethyl or nitro; or a pharmaceutically acceptable acid addition salt thereof, or where applicable an optical or geometrical isomer or racemic mixture thereof. The compounds of this invention are useful as glycine partial agonists and for the enhancement of learning and memory and in the treatment of memory dysfunction associated with neurodegenerative disorders and are thus indicated in the treatment of Alzheimer's disease and other senile demantias.
Patent DK-0629186-T3 (DK)
Inventor: BERGFELD MANFRED
IPC: C07B61/00
Filed: 1993-03-03
Granted: 1998-11-23
Abstract: A process is disclosed for preparing tertiary butylamine. Isobutene and ammonia are reacted with a special silica-alumina catalyst in very specific conditions, so that the tert-butylamine thus obtained has at least 99.5 % purity and can thus be directly used (further processed) without being finely distilled, once the low boiling educts have been separated (recycled).
Patent DK-0630252-T3 (DK)
Inventor: PILJAC GORAN
IPC: A61K8/00
Filed: 1993-02-04
Granted: 2005-04-04
Abstract: The invention relates to a pharmaceutical preparation comprising as an active ingredient at least one rhamnolipid or a pharmaceutically acceptable salt thereof, and a carrier and/or diluent, preferably comprising a rhamnolipid of general formula (I), wherein R1 = H, alpha-L-rhamnopyranosyl; R2 = H, (a); R3 = (C5-C20)-saturated, -mono- of poly-unsaturated alkyl; R4 = (C5-C20)-saturated, -mono- of poly-unsaturated alkyl. The preparation is used for the treatment of dermatological diseases, e.g. Papilloma virus infections.
Patent DK-0632076-T3 (DK)
Inventor: BROCK THOMAS DR
IPC: C09D175/04
Filed: 1994-06-27
Granted: 1999-05-25
Abstract: The invention relates to a process for the production of a multilayer finish by applying a base coat comprising an aqueous (water-borne) coating composition to a substrate and then applying a layer of a clear coat containing organic solvents, which gives coatings having excellent hardness and gloss. To this end, the base coat layer is produced by applying an aqueous coating composition, containing, in addition to water, one or more pigments and optionally one or more organic solvents, neutralisers and additives which are conventional in paints, as binder:  a combination of   I) from 99.5 to 85 % by weight of one or more aqueous, physically drying polyurethane binders having such a content of OH groups and acid functions that the OH number does not exceed 10 and the acid number does not exceed 30, of which from 10 to 50 % by weight based on the solids content of component I), can be replaced by one or more unsaturated products of the reaction of carboxyl-functional polycondensates with ethylenically unsaturated monomers, and II) from 0.5 to 15 % by weight of one or more polyisocyanates which are liquid at room temperature or have been liquefied by means of organic solvents and contain more than one free isocyanate group, from the group consisting of diisocyanates of the formula <IMAGE> in which the radicals R1 and R2 can in each case be identical or different and where     R1 = -H or -CnH2n+1   R2 = -CnH2n+1,   where n = an integer from 1 to 6 and A = a single bond, an aromatic or alicyclic radical or a linear or branched aliphatic radical having 1 to 12 carbon atoms, and/or polyisocyanates derived therefrom, where up to 40 % by weight, based on the solids content of the polyisocyanate component II, can be replaced by one or more different polyisocyanates which are liquid at room temperature or have been liquefied by means of organic solvents and contain more than one free isocyanate group, where the percentages by weight of the components I) and II) are in each case based on their solids content and add up to 100 % by weight, and where component II) is added to the coating composition just before its application.
Patent DK-0648121-T3 (DK)
Inventor: REMINGTON JACK S
IPC: A61K31/445
Filed: 1994-04-29
Granted: 1997-02-24
Abstract: A method of reducing the severity of toxoplasmosis resulring from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or before exposure to infection, a therapeutically effective amount of a compound that is a spiropiperidyl derivative of rifamycin S, wherein the derivative comprises an imidazole ring that includes carbons at positions 3 and 4 of the rifamycin ring, the carbon at position 2 of the imidazole ring also being a ring carbon at position 4 of a piperidine ring system, thereby forming a spiropiperidyl ring system, the spiropiperidyl ring system optionally comprising a lower hydrocarbon substituent on the nitrogen of the piperidine.
Patent DK-0680890-T3 (DK)
Inventor: HAN HAK-RHIM
IPC: B65D77/20
Filed: 1990-01-17
Granted: 1999-11-01
Abstract: A z-tab innerseal for a container involves an innerseal having a first sealing portion for sealing a first portion of an opening defined by an upper rim of a container, a second sealing portion for sealing the remainder of the container opening and a flap portion between the first and second sealing portions which is adapted to be grasped and pulled upwardly by a user to remove the innerseal from the container opening. In this respect the innerseal material ruptures and tears along a first edge (102) and along second and third edges (98, 104) generally perpendicular to the first edge such that a portion of the innerseal will remain bonded to the rim. <IMAGE>
Patent DK-0690426-T3 (DK)
Inventor: O'CONNELL CIARAN
IPC: G06F13/00
Filed: 1995-06-07
Granted: 2000-03-06
Abstract: A training system (1) has various media for interfacing with a user. A system controller (2) uses an interface file (17) to automatically execute action commands to perform an interfacing event. The action commands are delimited by interactivity point commands, execution of which halts an execution path and allows interactive inputs. A simulation program (19) may then be retrieved to allow the controller (2) simulate interfacing of the training subject. Screen controls are dynamically linked with simulation handlers of the simulation program. They are all disconnected after use of a simulation program. A combination of automatic interfacing and interactivity is achieved in a simple way for effective user training. <MATH>
Patent DK-0750509-T3 (DK)
Inventor: LEONARD JOHN P
IPC: C07K16/24
Filed: 1995-03-07
Granted: 2002-07-08
Abstract: Method of treating autoimmune conditions are disclosed comprising administering to a mammalian subject IL-12 or an IL-12 antagonist. In certain preferred embodiments the autoimmune condition is one which is promoted by an increase in levels of IFN-³ or TNF-±. Suitable conditions for treatment include multiple sclerosis, systemic lupus erythematosus, rheumatoid arthritis, autoimmune pulmonary inflammation, Guillain-Barre syndrome, autoimmune thyroiditis, insulin dependent diabetes melitis and autoimmune inflammatory eye disease.
Patent DK-0772465-T3 (DK)
Inventor: MAHONEY PETER M J
IPC: A61L27/00
Filed: 1995-07-14
Granted: 2003-08-11
Abstract: PCT No. PCT/EP95/02772 Sec. 371 Date Jul. 7, 1997 Sec. 102(e) Date Jul. 7, 1997 PCT Filed Jul. 14, 1995 PCT Pub. No. WO96/02285 PCT Pub. Date Feb. 1, 1996A non-immunogenic, bioerodible implantation composition which comprises alginate fibres.
Patent DK-0781201-T3 (DK)
Inventor: KLEPSCH WILHELM
IPC: B29C51/08
Filed: 1995-08-28
Granted: 1998-09-23
Abstract: A composite panel may be deep drawn into sanitary inserts (bath tubs, shower tubs, sinks, lavabos). A coating (3) of polymethyl metacrylate (PMMA, acrylic glass) is arranged on a substrate made in particular of acrylonitrile-butadiene-styrene (ABS). The acrylic glass coating consists of a mixture of impact-resistant modified PMMA and standard PMMA.
Patent DK-0767006-T3 (DK)
Inventor: BOERNER GUNTER DR
IPC: B05B5/03
Filed: 1996-09-27
Granted: 1999-11-01
Abstract: The method has the fluidisation occurring in a twin chambered device (2), the first chamber (3 )receiving the compressed air that then passes through a "frit" to the second chamber(4). The powder in the second chamber leaves the device from the nozzle (11) and is charged up. The powder is filled through the hole (9) which can be closed off. Apart from the nozzle and the air inlet and outlet valves (17,19), the fluidisation takes place in a closed chamber, the valves being used to maintain the correct pressure proportions. Additional mechanical energy is passed to the fluidised bed of the second chamber in the form of vibration.